Relation Therapeutics
PrivateLast Round
Corporate Funding
Dec 9, 2025
Total Funding Raised
$76.33M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Relation Therapeutics is a biotechnology company that discovers and develops medicines by leveraging its proprietary 'Lab-in-the-Loop' platform which integrates active-graph machine learning, single-cell multi-omics, and genomic data derived from human patient tissue.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Relation Therapeutics Comparables
Compare Relation Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Valo Health | 88% | |
| Insitro | 87% | |
| BenevolentAI | 86% |
Relation Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 9, 2025 | ||||
| Strategic | Dec 10, 2024 | ||||
| Seed | Mar 14, 2024 | ||||
| Early Stage VC | Jan 19, 2024 | ||||
| Seed | Jun 9, 2022 | ||||
Seed | Jul 1, 2021 |
Key People
Founding team and executive leadership
Relation Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetic Ventures | Corporate Funding, Seed |
| Deerfield Management | Seed |
| Firstminute Capital | Seed |
| Khosla Ventures | Seed |
| Magnetic Ventures | Seed, Corporate Funding |
| NVentures | Corporate Funding |
| The Bill & Melinda Gates Foundation Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
PatchDNA model recognized at NeurIPS AI4D3 workshop.
- Jan 1, 2026
Initiated in 2026 to address fibrosis and osteoarthritis.
Recent news
Latest coverage and updates
- launchesJul 30, 2026
Relation launched MORGAN on Jul 30th '26.
- partners_withJul 22, 2026
Relation Therapeutics Limited partnered with Deerfield Management Company on Jun 1st '26.
Relation Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Relation Therapeutics's valuation, stock price, and market status.
Is Relation Therapeutics a public or private company?
Relation Therapeutics is a private company.
What is the current stock price of Relation Therapeutics?
Relation Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Relation Therapeutics worth (valuation)?
Valuation information for Relation Therapeutics is not publicly available.
Can I buy Relation Therapeutics stock?
Relation Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Relation Therapeutics's last funding round?
Relation Therapeutics's most recent funding round was Early Funding on December 9, 2025.
Who are the main investors in Relation Therapeutics?
Key investors in Relation Therapeutics include Magnetic Ventures, NVentures, DCVC (Data Collective).
Will Relation Therapeutics IPO soon?
No public IPO plans have been announced for Relation Therapeutics.
How can I track Relation Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Relation Therapeutics's secondary market activity and sign up for updates.